RTIN Holdings, Inc. Announces

                           Resolution of Disputes with
                 MedEx Systems, Inc. and Pegasus Pharmacy, Inc.

Longview,  TX -- March 11, 2002 RTIN  Holdings  (NASD OTC BB:  RTNH),  announced
today that it had resolved  pending  disputes  arising from the  acquisition  of
MedEx System,  Inc. and Pegasus  Pharmacy,  Inc.  through  negotiation  with the
previous  shareholders  of  MedEx  and  Pegasus.  The  parties  entered  into  a
settlement  agreement  that provides for the  rescission of the  acquisition  of
MedEx and Pegasus by RTIN,  return of all of the RTIN common  stock  issued as a
result of the  acquisition,  and  return of the  outstanding  stock of MedEx and
Pegasus to the original shareholders. In exchange for the approximately $940,000
invested by RTIN in MedEx and Pegasus  since  November  2001,  RTIN  received an
exclusive,  perpetual,  paid-up  license to use the MedEx and  Pegasus  business
system, including ZipScript(TM),  in 157 metropolitan areas in the United States
and throughout the rest of the world. RTIN will do business under the names Safe
Med Systems, Inc. (TM) and Safe Script Pharmacies, Inc. (TM)

In connection with the settlement of the disputes,  Ms. Ann E. Rau resigned from
the position as a director of RTIN Holdings,  Inc. and Curtis  Swanson  resigned
from all  positions  as a director  of either  MedEx  Systems,  Inc.  or Pegasus
Pharmacy, Inc. RTIN, MedEx, Pegasus and their respective principals released the
others from any liability arising in connection with the acquisition.

Curtis A. Swanson,  President & Chief Operating Officer of RTIN Holdings stated,
"This is an equitable  outcome for RTIN, MedEx and Pegasus,  given the scope and
nature of the controversies. We are extremely pleased with this resolution. Even
though we are limited in the number of cities that we can  participate  in, this
agreement   enables  us  to  proceed  with  the  original  business  plan  while
eliminating  the overhead and debt  associated  with the MedEx  Systems Inc. and
Pegasus  Pharmacy Inc.  acquisition.  It also  eliminates the dilution of shares
associated  with  this  acquisition  which  should  enable us to  generate  more
earnings  on a per share  basis for 2002.  We can now enjoy a faster roll out of
pharmacy units and enhancements to the software."

Safe Med Systems,  Inc.(TM)is a medical technology  service provider,  providing
state-of-the-art, hand-held prescription units loaded with patent-pending secure
wireless software technologies. Safe Script Pharmacies, Inc.(TM)is the preferred
retail pharmacy provider that specializes in filling prescriptions  generated by
the Safe Med  Systems(TM)technology.  Because pain  management  specialists  and
their  patients  have been  under-served  by the  pharmacy  industry  and annual
expenditures for pain management is approaching $100 billion in the U.S. (and is
expected  to  grow),  the  companies  are  initially  targeting  physicians  who
frequently  treat  chronic pain.  For  additional  information  on both Safe Med
Systems,   Inc.  and  Safe  Script   Pharmacies,   Inc.  see  our  web  site  at
www.rtinholdings.com

RTIN Holdings, Inc., is a public holding company whose stock trades on the fully
reporting NASD OTC BB.

Contact:    Thomas   M.    Aigner   /    Director    of    Investor    Relations
tomaigner@rtinholdings.com or by telephone at 817-788-9716


--------------------------------------------------------------------------------
Certain  statements  in  this  news  release  may  constitute  "forward-looking"
statements  within the meaning of section 21E of the securities and Exchange Act
of 1934.  The Company  believes  that its  expectations,  as  expressed in these
statements  are  based  on  reasonable   assumptions  regarding  the  risks  and
uncertainties  inherent in achieving those  expectations.  These  statements are
not,  however,  guarantees of future  performance  and actual results may differ
materially.  The most important  factors that may cause actual results to differ
from  expectations  are the speed with which the  Company is able to install the
MedEx/Pegasus business system into the Safe Med and Safe Script business system,
the speed with which the Company is able to open pharmacy locations, the ability
of the Company to obtain  acceptance  of the  ZipScript by doctors and patients,
the  availability  of the necessary  capital for start-up  costs and the risk of
competitive  technology  innovations.  Other risk factors are listed in the most
recent Annual  Report on Form 10-KSB and  Quarterly  Report on Form 10-QSB filed
with the Securities and Exchange  Commission.  Such  forward-looking  Statements
involve  risks,  uncertainties  and other  factors,  which may cause the  actual
results,   performance,   or   achievement   expressed   or   implied   by  such
forward-looking statements to differ.
--------------------------------------------------------------------------------